More frequent placement of central venous catheter seen for patients with heart failure with reduced ejection fraction ...

Nissan Motor Co., Ltd. today announced changes to its senior management, introducing a significantly renewed leadership ...

Nissan has announced changes to its senior management, including the departure of CEO Makoto Uchida. The company said it is ...

Courts in England and Wales paralysed because the video platform used by witnesses and lawyers to attend hearings remotely ...

Patients with chronic kidney disease (CKD) and heart failure have higher rates of inpatient dialysis initiation than those ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

Motor announced changes to its senior management, introducing a significantly renewed leadership line-up to achieve the ...

The ailing Japanese automaker has fresh leadership - a new CEO is coming, and other senior management changes were just ...

Operator Greetings and welcome to the UiPath fourth quarter 2025 earnings conference call. At this time, all participants are ...

Chlorhexidine gluconate (CHG) is a widely used topical antiseptic that is recommended by the Centers for Disease Control and Prevention for skin cleansing before central venous catheter insertion ...

high-flux HD. Optimal vascular access through an arteriovenous fistula may help achieve high convection volume more effectively than a central venous catheter or graft. There are similar risks for ...

Q4 2025 Earnings Call Transcript March 12, 2025 UiPath Inc. beats earnings expectations. Reported EPS is $0.26, expectations ...